Apoptosis and the Pathogenesis of Endometriosis

Juan A. Garcia-Velasco; Aydin Arici

doi:10.1055/s-2003-41323

Seminars in Reproductive Medicine, Table of Contents

Semin Reprod Med 2003; 21(2): 165-172
DOI: 10.1055/s-2003-41323

Apoptosis and the Pathogenesis of Endometriosis

Juan A. Garcia-Velasco¹ , Aydin Arici²

¹IVI-Madrid, Madrid Spain,
²Section of Reproductive Endocrinology and Infertility, Department Of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut

Abstract

ABSTRACT

Apoptosis is a physiologic process that deletes unwanted cells without inducing an inflammatory reaction. Survival of endometriotic implants is associated with decreased apoptosis and an inflammatory environment. The most widely accepted theory-transplantation theory-related to the pathogenesis of endometriosis is supported by the description of abnormal survival of regurgitated endometrial cells. Eutopic endometrial cells from women with endometriosis also seem to resist apoptosis further when compared with cells from disease-free women. Several apoptotic pathways have been studied. Recent literature concerning apoptosis-related genes such as bcl-2/bax and fas/fas ligand is summarized in this article. Special emphasis is placed on sex steroid modulation and cell adhesion regulation, both relevant in early events of endometriosis.

KEYWORDS

Apoptosis - bcl-2 - fas ligand - endometrium

Full Text

References

REFERENCES

1 Ashkenazi A, Dixit V M. Death receptors: signaling and modulation. Science . 1998; 281 1305-1308
2 Clarke P G, Clarke S. Historic apoptosis. Nature . 1995; 378 230
3 Lincz L. Deciphering the apoptotic pathway: all roads lead to death. Immunol Cell Biol . 1998; 76 1-19
4 Kerr J F, Wyllie A H, Currie A R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer . 1972; 26 239-257
5 Cohen G M, Sun X-M, Snowden R T, Dinsdale D, Skilleter D N. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J . 1992; 286 331-334
6 Tsujimoto Y, Cossman J, Jaffe E, Croce C. Involvement of the bcl-2 gene in human follicular lymphoma. Science . 1985; 228 1440-1443
7 Vaux D, Cory S, Adams J. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature . 1988; 335 440-442
8 Hunter J J, Parslow T G. A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis. J Biol Chem . 1996; 271 8521-8524
9 Tilly J L. Apoptosis and ovarian function. Rev Reprod . 1996; 1 162-172
10 Nagata S, Golstein P. The Fas death factor. Science . 1995; 267 1449-1456
11 Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell . 1993; 75 1169-1178
12 Watanabe-Fukunaga R, Brannan C, Itoh N. et al . The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol . 1992; 148 1274-1279
13 Suda T, Okazaki T, Naito Y. et al . Expression of the Fas ligand in T-cell-lineage. J Immunol . 1995; 154 3806-3813
14 Nagata S. Fas and Fas ligand: a death factor and its receptor. Adv Immunol . 1994; 57 129-135
15 Dao T, Ohashi K, Kayano T, Kurimoto M, Okamura H. Interferon-γ-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol . 1996; 173 230-235
16 Strand S, Hofmann W, Hug H. et al . Lymphocyte apoptosis induced by CD94 (APO-1 Fas) ligand-expressing tumor cells: a mechanism of immune evasion?. Nat Med . 1996; 2 1361-1366
17 Nagata S. Apoptosis by death factor. Cell . 1997; 88 355-365
18 Griffith T, Brunner T, Fletcher S, Gree D, Ferguson T. Fas ligand induces apoptosis as a mechanism of immune privilege. Science . 1995; 270 1187-1192
19 Bellgrau D, Gold D, Selawry H. et al . A role for CD95 ligand in preventing graft rejection. Science . 1995; 377 630-632
20 Runic R, Lockwood C, Ma Y, Dipasquale B, Guller S. Expression of Fas ligand by human cytotrophoblast: implications in placentation and fetal survival. J Clin Endocrinol Metab . 1997; 81 3119-3122
21 Mor G, Gutierrez L, Eliza M, Kahyaoglu F, Arici A. Fas-Fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease. Am J Reprod Immunol . 1998; 39 89-94
22 Rabinowich H, Reichert T E, Kashii Y. et al . Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes. J Clin Invest . 1998; 101 2579-2588
23 Tabibzadeh S, Zupi E, Babaknia A. et al . Site and menstrual cycle-dependant expression of proteins of the tumour necrosis factor (TNF) receptor family, and BCL-2 oncoprotein and phase-specific production of TNFα in human reproduction. Hum Reprod . 1995; 10 277-286
24 Dahmoun M, Boman K, Cajander S. et al . Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of secretory phase. J Clin Endocrinol Metab . 1999; 84 1737-1743
25 Kokawa K, Shikone T, Nakano R. Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrinol Metab . 1996; 81 4144-4147
26 Garcia-Velasco J A, Arici A, Zreik T, Naftolin F, Mor G. Macrophage-derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis. Mol Hum Reprod . 1999; 5 642-650
27 Gebel H M, Braun D P, Tambur A. et al . Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis. Fertil Steril . 1998; 69 1042-1047
28 Dmowski W P. Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis. Hum Reprod . 2001; 16 1802-1808
29 Meresman G F, Vighi S, Buquet R A. et al . Apoptosis and expression of bcl-2 and bax in eutopic endometrium of women with endometriosis. Fertil Steril . 2000; 74 760-766
30 Suganuma N, Harada M, Furuhashi M, Nawa A, Kikkawa F. Apoptosis in human endometrial and endometriotic tissues. Horm Res . 1997; 48 (suppl 1) 42-47
31 Harada M, Suganuma N, Furuhashi M. et al . Detection of apoptosis in human endometriotic tissues. Mol Hum Reprod . 1996; 2 307-315
32 Meredith J, Fazeli B, Schwartz M. The extracellular matrix as a survival factor. Mol Biol Cell . 1993; 4 953-961
33 Aplin A E, Howe A, Alahari S K, Juliano R L. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev . 1998; 50 197-263
34 Franke T F, Cantley L C. A bad kinase makes good. Nature . 1997; 390 116-117
35 Wary K K, Mainiero F, Isakoff S J, Marcantonio E E, Giancotti F G. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell . 1996; 87 733-743
36 Shy J-J, Chien S. Role of integrins in cellular responses to mechanical stress and adhesion. Curr Opin Cell Biol . 1997; 9 707-713
37 Koh E, Illingworth P, Duncan W, Critchley H. Immunolocalization of bcl-2 protein in human endometrium in the menstrual cycle and simulated early pregnancy. Mol Hum Reprod . 1995; 10 1557-1562
38 Otsuki Y, Misaki O, Sugimoto O. et al . Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle. Lancet . 1994; 344 28-29
39 Jones R, Searle R, Stewart J, Turner S, Bulmer J. Apoptosis, bcl-2 expression, and proliferative activity in human endometrial stroma and endometrial granulated lymphocytes. Biol Reprod . 1998; 58 995-1002
40 Yamashita H, Otsuki Y, Ito Y. et al . Fas ligand, Fas antigen and Bcl-2 expression in human endometrium during the menstrual cycle. Mol Hum Reprod . 1999; 5 358-364
41 Meresman G, Augé L, Barañao R I. et al . Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril . 2002; 77 1141-1147
42 McLaren J, Prentice A, Charnock-Jones D, Sharkey A, Smith S. Immunolocalization of the apoptosis regulating proteins Bcl-2 and Bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis. Hum Reprod . 1997; 12 146-152
43 Juliano R L, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol . 1993; 120 577-585
44 Spuijbroek M E H D, Dunselman G AJ, Menheere P C A P, Evers J LH. Early endometriosis invades the extracellular matrix. Fertil Steril . 1992; 58 929-933
45 Witz C A, Motoya-Rodríguez I A, Schenken R S. Whole explants of peritoneum and endometrium: a novel model of the early endometriosis lesion. Fertil Steril . 1999; 71 56-60
46 Garcia-Velasco J A, Arici A. Chemokines in human reproduction. Infertil Reprod Med Clin North Am . 2002; 13 129-144
47 Simón C, Caballero P, Garcia-Velasco J A, Pellicer A. Potential implications of chemokines in reproductive function: an attractive idea. J Reprod Immunol . 1998; 38 169-193
48 Garcia-Velasco J A, Seli E, Arici A. Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by integrin-dependent cell adhesion. Biol Reprod . 1999; 61 548-552
49 Garcia-Velasco J A, Arici A. Interleukin-8 expression in endometrial stromal cells is regulated by integrin-dependent cell adhesion. Mol Hum Reprod . 1999; 12 1135-1140
50 Selam B, Kayisli U A, Garcia-Velasco J A, Arici A. Extracellular matrix-dependent regulation of Fas ligand expression in human endometrial stromal cells. Biol Reprod . 2002; 66 1-5
51 Arici A, Tazuke S I, Attar E, Kliman H J, Olive D L. Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum Reprod . 1996; 2 40-45
52 Ryan I P, Tseng J F, Schriock E D. et al . Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril . 1995; 63 929-932
53 Selam B, Kayisli U A, Garcia-Velasco J A, Akbas E, Arici A. Regulation of Fas ligand expression by interleukin-8 in human endometrium. J Clin Endocrinol Metab . 2002; 87 3921-3927
54 Kayagaki N, Kawasaki A, Ebata T. et al . Metalloproteinase-mediated release of human Fas ligand. J Exp Med . 1995; 182 1777-1783
55 Tanaka M, Suda T, Haze K. et al . Fas ligand in human serum. Nat Med . 1996; 2 317-322
56 Osteen K G, Bruner-Tan K L, Ong D, Eisenberg E. Paracrine mediators of endometrial matrix metalloproteinases expression: potential targets for progestin-based treatment of endometriosis. Ann NY Acad Sci . 2002; 955 139-146
57 Garcia-Velasco J A, Mulayim N, Kayisli U A, Arici A. Elevated soluble Fas ligand levels may suggest a role for apoptosis in women with endometriosis. Fertil Steril . 2002; 78 855-859